Trading Signals: EYES Stock Price Prediction and Forecast (Thu. Mar. 10, 2016 - Mon. Jun. 28, 2021)(Second Sight Medical Products Inc)
| EYES latest price $6.8544 (-0.38%) ($6.6232 - $6.9600) on Fri. Nov. 22, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.66% (three month average) | RSI | 73 | Latest Price | $6.8544(-0.38%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EYES declines -0.7% a day on average for past five trading days. | Weekly Trend | EYES advances 1.8% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support EYES advance at 0% a week (0% probability) TAN(8%) UNG(8%) IGOV(7%) FIVG(4%) ICLN(4%) | Factors Impacting EYES price | EYES will decline at least -1.83% in a week (0% probabilities). BND(-8%) XLP(-6%) XLK(-6%) QQQ(-6%) LQD(-6%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.83% (StdDev 3.66%) | Hourly BBV | 0 () | Intraday Trend | 0.7% | | | |
|
5 Day Moving Average | $6.84(0.21%) | 10 Day Moving Average | $6.95(-1.38%) | 20 Day Moving Average | $6.7(2.3%) | To recent high | -10.7% | To recent low | 18.1% | Market Cap | $2.189b | | | | Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company's headquarters are in Los Angeles, California. |